Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
researchers at Bristol University and external institutions. You will work in the laboratory on a range of molecular projects which may include next-generation sequencing and library preparation, nucleic acid
-
the laboratory is expected. The overarching aim of the project is to use multi-disciplinary approaches (particularly recombinant protein expression and purification, molecular biology, and eukaryotic cell biology
-
of the research group as necessary. You will record the results of their experiments and describe them during regular lab meetings. Experience of working in a molecular biology laboratory with extensive experience
-
will be ideally suited to the role. You must have extensive molecular biology experience, ideally having experience with multiple genetic models. Experience of tissue culture and in situ hybridisation
-
have extensive molecular biology experience, ideally having experience with multiple genetic models. Experience of tissue culture and in situ hybridisation or immunolocalization will be advantageous. You
-
programme at the Universities of Bristol and Oxford, as well as Imperial College London. You will focus on the development of a computational platform to accelerate our ability to engineer biology across
-
proliferation, in the context of cardiac fibrosis. The project will involve using a wide range of molecular cell biology techniques, in silico molecular modelling and ex vivo experimental models. The successful
-
, lenti-viral transduction, manufacture of pMHCI tetramers and molecular biology. The successful candidate will join the Clinical T-cell Immunology research group which is led by Professor Linda Wooldridge
-
Adam Finn ) in the BVC Immunology Laboratory Group with other trainees and experienced technical staff. The post is based at the School of Cellular and Molecular Medicine, University of Bristol
-
at the University of Bristol. The post-holder will use state-of-the-art protein engineering and display technology to generate high-affinity nanobodies against diverse toxins from snake venoms. These will be selected